Teva Pharmaceutical Industries Limited
TEVA
739 hedge funds and large institutions have $21.9B invested in Teva Pharmaceutical Industries Limited in 2016 Q4 according to their latest regulatory filings, with 118 funds opening new positions, 241 increasing their positions, 304 reducing their positions, and 164 closing their positions.
23% more capital inflows, than outflows
Capital inflows: $6.08B | Capital outflows: $4.94B
1.49% less ownership
Funds ownership: 56.08% → 54.59% (-1.5%)
7% less funds holding
Funds holding: 798 → 739 (-59)
20% less funds holding in top 10
Funds holding in top 10: 35 → 28 (-7)
21% less repeat investments, than reductions
Existing positions increased: 241 | Existing positions reduced: 304
28% less first-time investments, than exits
New positions opened: 118 | Existing positions closed: 164
33% less call options, than puts
Call options by funds: $433M | Put options by funds: $645M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$939M |
| 2 |
BlackRock Institutional Trust
San Francisco,
California
|
+$502M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$390M |
| 4 |
Highfields Capital Management
Boston,
Massachusetts
|
+$347M |
| 5 |
BlackRock Fund Advisors
San Francisco,
California
|
+$289M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$906M |
| 2 |
PointState Capital
New York
|
-$416M |
| 3 |
Lazard Asset Management
New York
|
-$285M |
| 4 |
Waddell & Reed Financial
Overland Park,
Kansas
|
-$265M |
| 5 |
BlackRock Advisors
Wilmington,
Delaware
|
-$186M |
TEVA Hedge Fund Activity: Q4 2016 in Review
739 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceutical Industries Limited (TEVA) for Q4 2016, worth a combined $21.9B — down 16% from $26.2B a quarter earlier.
Sellers outnumbered buyers: 164 funds closed out of TEVA and 118 opened new positions — a net loss of 46 holders — while 304 trimmed existing stakes and 241 added.
The largest buyer was Capital Research Global Investors, adding an estimated $939M. The largest seller was Viking Global Investors, exiting entirely with an estimated $906M sold.
- 739 institutional investors held Teva Pharmaceutical Industries Limited (TEVA) as of Q4 2016, down from 798 in Q3 2016.
- Funds reported $21.9B of Teva Pharmaceutical Industries Limited stock for Q4 2016, down 16% quarter-over-quarter.
- 118 funds opened new Teva Pharmaceutical Industries Limited positions in Q4 2016 and 164 closed out, a net change of -46 holders.
- The largest Teva Pharmaceutical Industries Limited buyer in Q4 2016 was Capital Research Global Investors, an estimated $939M added.
- The largest Teva Pharmaceutical Industries Limited seller in Q4 2016 was Viking Global Investors, an estimated $906M sold.
Based on aggregated 13F filings for Q4 2016.